Guardant Health Inc
NASDAQ:GH

Watchlist Manager
Guardant Health Inc Logo
Guardant Health Inc
NASDAQ:GH
Watchlist
Price: 30.93 USD -2.15% Market Closed
Market Cap: 3.8B USD
Have any thoughts about
Guardant Health Inc?
Write Note

Guardant Health Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guardant Health Inc
Research & Development Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Guardant Health Inc
NASDAQ:GH
Research & Development
-$344.1m
CAGR 3-Years
-14%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Guardant Health Inc's Research & Development?
Research & Development
-344.1m USD

Based on the financial report for Sep 30, 2024, Guardant Health Inc's Research & Development amounts to -344.1m USD.

What is Guardant Health Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-35%

Over the last year, the Research & Development growth was 10%. The average annual Research & Development growth rates for Guardant Health Inc have been -14% over the past three years , -35% over the past five years .

Back to Top